{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:33:55Z","timestamp":1793104435061,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"10","content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.tem.2013.06.002","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T05:30:28Z","timestamp":1374211828000},"page":"481-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["AMPK: mediating the metabolic effects of salicylate-based drugs?"],"prefix":"10.1016","volume":"24","author":[{"given":"Gregory R.","family":"Steinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Dandapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Grahame","family":"Hardie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2013.06.002_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.phyto.050908.135202","article-title":"Salicylic acid, a multifaceted hormone to combat disease","volume":"47","author":"Vlot","year":"2009","journal-title":"Annu. Rev. Phytopathol."},{"key":"10.1016\/j.tem.2013.06.002_bib0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1073\/pnas.84.5.1417","article-title":"Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity","volume":"84","author":"Higgs","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2013.06.002_bib0015","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.1215327","article-title":"The ancient drug salicylate directly activates AMP-activated protein kinase","volume":"336","author":"Hawley","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.tem.2013.06.002_bib0020","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","article-title":"Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells","volume":"142","author":"Din","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tem.2013.06.002_bib0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.tem.2013.06.002_bib0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Ann. Rev. Pharm. Toxicol."},{"key":"10.1016\/j.tem.2013.06.002_bib0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2125.1989.tb03423.x","article-title":"Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis","volume":"27","author":"Preston","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tem.2013.06.002_bib0040","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.96.11.6377","article-title":"Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB","volume":"96","author":"Cronstein","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2013.06.002_bib0045","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.tem.2013.06.002_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I\u03baB kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.tem.2013.06.002_bib0055","series-title":"Kinase Inhibitor Database","author":"International Centre for Kinase Profiling","year":"2013"},{"key":"10.1016\/j.tem.2013.06.002_bib0060","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2013.06.002_bib0065","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tem.2013.06.002_bib0070","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes","volume":"109","author":"Hundal","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2013.06.002_bib0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2013.06.002_bib0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-012-2819-3","article-title":"A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance","volume":"56","author":"Goldfine","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.06.002_bib0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2013.06.002_bib0090","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/jc.2010-1816","article-title":"Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions","volume":"96","author":"Meex","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.06.002_bib0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/00365517809108413","article-title":"Mechanisms for inhibition of free fatty acid mobilization by nicotinic acid and sodium salicylate in canine subcutaneous adipose tissue in situ","volume":"38","author":"Vik-Mo","year":"1978","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.tem.2013.06.002_bib0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0300-483X(82)90060-9","article-title":"Inhibition of hepatic lipogenesis by salicylate","volume":"24","author":"Beynen","year":"1982","journal-title":"Toxicology"},{"key":"10.1016\/j.tem.2013.06.002_bib0105","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","article-title":"AMPK in health and disease","volume":"89","author":"Steinberg","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2013.06.002_bib0110","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.chembiol.2012.08.019","article-title":"AMP-activated protein kinase: a target for drugs both ancient and modern","volume":"19","author":"Hardie","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tem.2013.06.002_bib0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-4924-2-28","article-title":"Complexes between the LKB1 tumor suppressor, STRAD\u03b1\/\u03b2 and MO25\u03b1\/\u03b2 are upstream kinases in the AMP-activated protein kinase cascade","volume":"2","author":"Hawley","year":"2003","journal-title":"J. Biol."},{"key":"10.1016\/j.tem.2013.06.002_bib0120","doi-asserted-by":"crossref","first-page":"E310","DOI":"10.1152\/ajpendo.00074.2004","article-title":"Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR","volume":"287","author":"Sakamoto","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.06.002_bib0125","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","article-title":"LKB1 is a master kinase that activates 13 protein kinases of the AMPK subfamily, including the MARK\/PAR-1 kinases","volume":"23","author":"Lizcano","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.tem.2013.06.002_bib0130","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1126\/science.1200094","article-title":"AMPK is a direct adenylate charge-regulated protein kinase","volume":"332","author":"Oakhill","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tem.2013.06.002_bib0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09932","article-title":"Structure of mammalian AMPK and its regulation by ADP","volume":"472","author":"Xiao","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tem.2013.06.002_bib0140","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2010.04.001","article-title":"Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation","volume":"11","author":"Hawley","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.06.002_bib0145","doi-asserted-by":"crossref","first-page":"32549","DOI":"10.1074\/jbc.M706536200","article-title":"Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase","volume":"282","author":"Goransson","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2013.06.002_bib0150","doi-asserted-by":"crossref","first-page":"32539","DOI":"10.1074\/jbc.M706543200","article-title":"Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family","volume":"282","author":"Sanders","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2013.06.002_bib0155","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.chembiol.2008.10.005","article-title":"Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes","volume":"15","author":"Scott","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tem.2013.06.002_bib0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo","volume":"17","author":"Faubert","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.06.002_bib0165","doi-asserted-by":"crossref","first-page":"25250","DOI":"10.1074\/jbc.M414222200","article-title":"Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes","volume":"280","author":"Daval","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2013.06.002_bib0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1432-1033.1989.tb14548.x","article-title":"Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism","volume":"179","author":"Garton","year":"1989","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.tem.2013.06.002_bib0175","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","article-title":"AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan","volume":"89","author":"Salminen","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.tem.2013.06.002_bib0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/BJ20101517","article-title":"Counter-modulation of fatty acid-induced pro-inflammatory nuclear factor kappaB signalling in rat skeletal muscle cells by AMP-activated protein kinase","volume":"435","author":"Green","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.tem.2013.06.002_bib0185","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK and pseudo-starvation","volume":"493","author":"O\u2019Neill","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tem.2013.06.002_bib0190","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2012-03-419747","article-title":"Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells","volume":"120","author":"Everts","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tem.2013.06.002_bib0195","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tem.2013.06.002_bib0200","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cmet.2012.04.023","article-title":"The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism","volume":"15","author":"Haschemi","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.06.002_bib0205","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.4049\/jimmunol.181.12.8633","article-title":"Adenosine 5\u2032-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype","volume":"181","author":"Sag","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2013.06.002_bib0210","doi-asserted-by":"crossref","first-page":"19051","DOI":"10.1074\/jbc.M110.123620","article-title":"Macrophage \u03b11-AMP-activated protein kinase (\u03b11AMPK) antagonizes fatty acid-induced inflammation through SIRT1","volume":"285","author":"Yang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2013.06.002_bib0215","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1172\/JCI58577","article-title":"Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity","volume":"121","author":"Galic","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2013.06.002_bib0220","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1084\/jem.20052469","article-title":"Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes","volume":"203","author":"Tamas","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tem.2013.06.002_bib0225","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.1100367","article-title":"The liver kinase B1 is a central regulator of T cell development, activation, and metabolism","volume":"187","author":"MacIver","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2013.06.002_bib0230","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/eji.201243008","article-title":"AMPKalpha1: a glucose sensor that controls CD8 T-cell memory","volume":"43","author":"Rolf","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tem.2013.06.002_bib0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08097","article-title":"Enhancing CD8 T-cell memory by modulating fatty acid metabolism","volume":"460","author":"Pearce","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.tem.2013.06.002_bib0240","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tem.2013.06.002_bib0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2013.06.002_bib0250","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","article-title":"Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)","volume":"87","author":"Oshima","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.tem.2013.06.002_bib0255","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/cncr.27817","article-title":"Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative","volume":"119","author":"Gamba","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.tem.2013.06.002_bib0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2013.06.002_bib0265","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ejca.2012.09.030","article-title":"Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level","volume":"49","author":"Veitonmaki","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tem.2013.06.002_bib0270","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/bjc.2012.227","article-title":"Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study","volume":"107","author":"Shebl","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tem.2013.06.002_bib0275","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1634\/theoncologist.2011-0462","article-title":"Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis","volume":"17","author":"Soranna","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.tem.2013.06.002_bib0280","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1349-7006.2008.00933.x","article-title":"Metformin suppresses intestinal polyp growth in ApcMin\/+ mice","volume":"99","author":"Tomimoto","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tem.2013.06.002_bib0285","series-title":"Aspirin: The Remarkable Story of a Wonder Drug","author":"Jeffreys","year":"2004"},{"key":"10.1016\/j.tem.2013.06.002_bib0290","first-page":"319","article-title":"Uber den Stoffwechsel der Tumoren","volume":"152","author":"Warburg","year":"1924","journal-title":"Biochem. Z"},{"key":"10.1016\/j.tem.2013.06.002_bib0295","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2013.06.002_bib0300","doi-asserted-by":"crossref","first-page":"26146","DOI":"10.1074\/jbc.M301981200","article-title":"Multiple pathways are co-regulated by the protein kinase Snf1 and the transcription factors Adr1 and Cat8","volume":"278","author":"Young","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276013001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276013001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T13:00:56Z","timestamp":1539522056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276013001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1043276013001045"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2013.06.002","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AMPK: mediating the metabolic effects of salicylate-based drugs?","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2013.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}